Boston
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
495- Dermatology
- 385
- Plastic Surgery
- 110
Vendor qualification for medspas operating under physician supervision
Medspas that operate under a supervising physician typically need the same vendor documentation a dermatology or plastic surgery practice would request: a certificate of analysis per lot, a donor eligibility summary, and confirmation of the quarantine and sterility testing process before a lot is released.
Because medspas operate under physician supervision, the supervising physician or medical director is generally the party responsible for vendor sign-off and intended-use review, not administrative staff.
NPI-verified accounts across practice types
Account verification requires an NPI number, which applies equally to a dermatology practice, a plastic surgery practice, and a medspa operating under its medical director's license. Precision Biologics does not open accounts for unverified or non-clinical buyers.
Cold-chain and ambient shipping
Cryopreserved products are shipped overnight on dry ice in validated containers after slow-rate freezing and storage at -80 degrees Celsius; lyophilized exosome and Wharton's jelly formats ship at ambient conditions and are shelf-stable per the supplier's storage guidance. Either way, the lot number should be logged at receipt and again at use so the practice maintains traceability.
- Cryopreserved: overnight, dry ice, validated packaging
- Lyophilized: ambient shipping, shelf-stable storage
- Lot number logged at receipt and at point of use
Confirming oversight with your medical board and counsel
Massachusetts medspas and aesthetic practices should confirm medical-director oversight requirements and intended-use questions with the Massachusetts Board of Registration in Medicine and their own counsel before adding a new biologics vendor. Precision Biologics supports account setup and documentation but does not advise on clinical use, indications, or protocol.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can our medspa open an account if we operate under a supervising physician rather than as a physician-owned practice?+
Yes, provided the account is verified against a valid NPI number, consistent with how dermatology and plastic surgery practices are verified.
Do you publish pricing for medspas in Boston?+
Pricing is available to verified accounts rather than published, since terms vary by account type and order volume.
What documentation differentiates a Wharton's jelly product from an exosome product in your catalog?+
Wharton's jelly products are offered under the supplier's HCT/P framework with a donor eligibility summary and certificate of analysis. Exosome products are not FDA approved, are generally regulated as biologic drugs, and ship with supplier-reported characterization data and full ingredient disclosure instead.